EU-Startups· Rahul Raj·· 11 days agoTop DealsAI Score71
Oxford spin-out Alethio Therapeutics raises €80.46M Series A for targeted blood cancer therapies
Oxford spin-out Alethio Therapeutics raises €80.46 million Series A to advance targeted blood cancer therapies
AI Overview
Alethio Therapeutics, an Abingdon-on-Thames biopharma spun out of the University of Oxford in 2021.
Why it matters
The round's syndicate and the ATX-011 timeline show how a University of Oxford spin-out is moving a targeted MPN antibody toward Phase 1/2a.
Source:EU-Startups · eu-startups.com